Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1/2 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 4Stomach Neoplasms 2Carcinoma, Hepatocellular 2Symptom Management 1Pain 1Neoplasms 1Lymphedema 1Hemorrhage 1Cholangiocarcinoma 1Carcinoma 1Cancer Survivors 1Bites and Stings 1

Interventions

Sorafenib 46lenvatinib 44apatinib 23sintilimab 22Fluorouracil 21camrelizumab 20Oxaliplatin 17Radiofrequency Ablation 16Radiosurgery 15Hepatectomy 15tislelizumab 14Leucovorin 14Radiotherapy 12Doxorubicin 12toripalimab 11Folfox protocol 10Bevacizumab 10Immune Checkpoint Inhibitors 9Epirubicin 9regorafenib 8Ethiodized Oil 8durvalumab 7donafenib 7anlotinib 7Neoadjuvant Therapy 7pembrolizumab 6entecavir 6Surgical Procedures, Operative 6Nivolumab 6Injections 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Hepatocellular × Palliative Care × Clear all
NCT01392131 2012-12-12

Safety and Efficacy of Oncoxin in Hepatocellular Carcinoma (HCC)

Clinical Research Organization, Dhaka, Bangladesh

Phase 1/2 Unknown
40 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01438450 2012-07-13

OTCHCC

All India Institute of Medical Sciences

Phase 2/3 Unknown
74 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡